Account Executive, Diagnostic Solutions - Alabama jobs in United States
cer-icon
Apply on Employer Site
company-logo

BD · 1 week ago

Account Executive, Diagnostic Solutions - Alabama

BD is one of the largest global medical technology companies in the world. As the Diagnostic Solutions Account Executive, you will be responsible for developing and implementing strategic sales plans to drive growth for the product portfolio across multiple stakeholders and buyers.

Health CareMedical DeviceTechnical Support
check
Comp. & Benefits

Responsibilities

Develop and execute territory and strategic account sales plans involving multiple stakeholders and buyers to grow assigned products
Effectively deploy clinically relevant product features, benefits, and economic justification to define the value of our offerings
Coordinate decision makers and influencers across the customer buying process to secure contractual purchase agreements
Attain or exceed overall sales plan for the DS product portfolio, including Manual Microbiology, Blood Culture, TB, ID/AST, and Molecular Diagnostics
Manage the sales process across clinical laboratory, infectious disease clinicians, pharmacy, value analysis, and hospital administration
Create demand, deliver product information and demonstrations, and orchestrate new customer acquisition strategies
Develop account strategies and close accounts within the assigned territory using a coordinated team selling model

Qualification

Sales successClinical laboratory experienceAccount managementLife Sciences degreeMedical Technology certificationStrategic planningCollaborationCommunication skills

Required

Bachelor's degree in Life Sciences, biological areas, business, or a related field is required
Minimum 3 years of documented top 20% sales success in a broad range of laboratory products, with at least 1 year of clinical laboratory and/or hospital sales experience is required
A combination of clinical market sales, financial, or technical selling experience is required

Preferred

A degree in Medical Technology (MT ASCP) or Microbiology

Company

BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.

Funding

Current Stage
Public Company
Total Funding
$540M
Key Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO

Leadership Team

leader-logo
Tom Polen
Chairman, CEO and President
linkedin
leader-logo
Richard Byrd
Executive Vice President and President Interventional Segment
linkedin
Company data provided by crunchbase